Sudarshan Pharma Industries Share Price
Small Cap | Pharmaceuticals and health care | BSE: 543828
₹29.00 
-0.51 (-1.73 %)
Last Updated: 13 Mar 2025 12:00 AM
BEARISH
Overview
Open (₹) 29.51
High (₹) 29.75
Low (₹) 29.00
Prev. Close (₹) 29.51
Volume 24,000
VWAP (₹) 29.35
ROCE (%) 19.76
Industry P/E 43.95
TTM P/E 55.77
P/B Ratio 0.62
Market Cap (₹) Cr.697.91
Dividend Yield (%)--
EPS (₹) 4.76
ROE10.25%
Sales Growth (%) 0.48
Profit Growth (%)62.79
Day Range
29.7529.75
52 Week Range
5.8253.50
Historical Returns
Returns (6M)
-4.16 %
Returns (1Y)
268.96 %
Returns (3Y)
317.87 %
Returns (5Y)
317.87 %
Returns (6M)
-4.16 %
Returns (1Y)
268.96 %
Returns (3Y)
317.87 %
Returns (5Y)
317.87 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Increasing Annual Revenue for Past 2 Years
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
Technicals
Technical Rating
BEARISHRSI 46.74
MFI 12.19
ATR 1.69
Commodity Channel Index -156.33
ROC125 71.35
ROC21 -32.08
Williams %R -100.00
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 29.36 | 29.43 | 29.46 | 29.33 | 29.26 | 29.23 | 29.16 |
| Week Ago | 34.23 | 35.54 | 36.35 | 33.42 | 32.11 | 31.30 | 29.99 |
| Month Ago | 42.30 | 42.30 | 42.30 | 42.30 | 42.30 | 42.30 | 42.30 |
EMA & SMA
29.00
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
18
5 Day 32.09
9 Day 32.91
10 Day 33.17
12 Day 33.97
14 Day 34.27
20 Day 36.25
26 Day 37.80
50 Day 40.86
100 Day 40.60
200 Day 27.92
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| NORTH STAR OPPORTUNITIES FUND VCC-BULL VALUE INCORPORATED VCC SUB-FUND | bulk | Buy | 11 Feb, 2025 | ₹35.73 | 15,00,000 | BSE |
| MANSI SHARE & STOCK ADVISORS PRIVATE LIMITED | bulk | Sell | 01 Jan, 2025 | ₹44.35 | 12,48,000 | BSE |
| SETU SECURITIES PVT LTD | bulk | Buy | 01 Jan, 2025 | ₹44.35 | 12,48,000 | BSE |
| CENTURY INDIA OPPORTUNITY FUND PC | bulk | Buy | 28 Nov, 2024 | ₹41.97 | 16,00,000 | BSE |
| SAROJ GUPTA | bulk | Sell | 25 Sept, 2024 | ₹424.35 | 75,200 | BSE |
| EPITOME TRADING AND INVESTMENTS | bulk | Sell | 25 Sept, 2024 | ₹421.92 | 1,53,600 | BSE |
| SAROJ GUPTA | bulk | Buy | 25 Sept, 2024 | ₹411.00 | 1,50,400 | BSE |
| EPITOME TRADING AND INVESTMENTS | bulk | Buy | 25 Sept, 2024 | ₹424.33 | 1,34,400 | BSE |
| BISHWANATH PRASAD AGRAWAL | bulk | Buy | 25 Sept, 2024 | ₹412.41 | 1,39,200 | BSE |
| SHYAMSAKHA BROKING SERVICES PRIVATE LIMITED | bulk | Sell | 23 Sept, 2024 | ₹385.85 | 1,31,200 | BSE |
Insider Trading
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 30 Sept, 2024 | Stock split from Rs. 10/- to Re. 1/-. | 22 Nov, 2024 | 23 Nov, 2024 |
| 26 May, 2023 | Rs.0.3000 per share(3%)Final Dividend | 25 Aug, 2023 | 01 Jan, 1970 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 06 Mar, 2025 | BSE India | We inform you that at the meeting of Board of Directors of the Company on 6th March, 2025 the Board has, on the recommendation of the Nomination and Remuneration Committee, with Consent of Mr. Manoj Lodha, appointed Mr. Manoj Lodha as an Executive Director and Chief Financial Officer of the Company w.e.f. 1st April, 2025. |
| 06 Mar, 2025 | BSE India | We inform you that the Board of Director have accepted the resignation of Mr. Sachin Mehta as Chief Financial Officer of the Company w.e.f. 1st April, 2025, However Mr. Sachin Mehta shall continue as the Joint Managing Director of the Company. |
| 04 Mar, 2025 | BSE India | Pursuant to Regulation 30(6) of SEBI Listing Regulations, this is to inform you that the Company will be meeting Investors / Analysts on 07-March-2025. \r\n\r\nKindly take the same on record. |
| 26 Feb, 2025 | BSE India | In continuation of the Company''s disclosure dated 29-Nov-2024, this is to inform you that the Company has acquired 10,000 ordinary shares of Sudarshan Pharma Industries Private Limited, Singapore (Unique Entity Number 202327475M). \r\n\r\nConsequent to the aforesaid acquisition, Sudarshan Pharma Industries Private Limited has become a wholly-owned subsidiary of the Company. |
| 19 Feb, 2025 | BSE India | This is to inform you that the Board of Directors of the Company have approved to incorporate a limited liability company in Poland as a wholly-owned subsidiary. Details required vide SEBI circular dated 13-July-2023 are given in the annexure. |
| 05 Feb, 2025 | BSE India | Pursuant to Regulation 44(3) of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, please find enclosed the Scrutinizer''s Report on the business transacted at the Extraordinary General Meeting of the Company held on Tuesday, 5th February 2025 through video conferencing / other audio-visual means. |
| 05 Feb, 2025 | BSE India | Pursuant to Regulation 44 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, please find enclosed the voting results on the business transacted at the Extraordinary General Meeting of the Company held on Tuesday, 4th February 2025 at 3.00 pm through video conferencing / other audio-visual means. |
| 04 Feb, 2025 | BSE India | We inform you that an Extraordinary General Meeting of the Company was held on Tuesday, 4th February 2025 at 3.00 pm through video conferencing / other audio visual means. Pursuant to Regulation 30 and part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a summary of the proceedings of Extraordinary General Meeting. |
| 31 Jan, 2025 | BSE India | Corrigendum to Notice of Extra-Ordinary General Meeting dated 10-Jan-2025 about certain alterations / modifications / additions made in the Resolution and Explanatory Statement pertaining to item no. 1 of EGM Notice dated 10-Jan-2025. |
| 31 Jan, 2025 | BSE India | In continuation of the outcome of Board Meeting held on 10-Jan-2025, Fund Raising Committee of the Board at its meeting held on 30-Jan-2025 approved, inter alia, revision in list of allottees and change in Notice of EGM and issue of Corrigendum to the Notice of Extraordinary General Meeting scheduled on Tuesday, 04-Feb-2025. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| To consider issue of Warrants | -- | 06 Jan, 2025 | 10 Jan, 2025 |
| Half Yearly Results | -- | 28 Oct, 2024 | 31 Oct, 2024 |
| Stock Split | -- | 25 Sept, 2024 | 30 Sept, 2024 |
| Others | Inter alia, (1) To consider proposal for raising of funds by way of issue of one or more of instruments comprising of equity shares, convertible securities of any other description or warrants etc. | 17 Jul, 2024 | 04 Jul, 2024 |
| Audited Results | -- | 22 May, 2024 | 27 May, 2024 |
| Others | Inter alia, to consider : 1. To give authority to appoint consultants and/or representatives. 2. To avail the credit facility. | 23 Mar, 2024 | 28 Mar, 2024 |
| Half Yearly Results & ESOP | -- | 06 Nov, 2023 | 10 Nov, 2023 |
| Others | Inter alia, to consider : To give approval for incorporating a subsidiary company in the name and style of "LIFESCIENCES CHEMICAL PRIVATE LIMITED", in the state of Gujarat. | 17 Aug, 2023 | 18 Aug, 2023 |
| Others | -- | 28 Jul, 2023 | 02 Aug, 2023 |
| Final Dividend & ESOP | -- | 18 Jul, 2023 | 21 Jul, 2023 |
Share Holding Pattern
| Owner Name | Sept, 2024 | Mar, 2024 | Sept, 2023 |
|---|
About Sudarshan Pharma Industries
Sudarshan Pharma Industries is a Public Limited Listed company incorporated on 23/07/2008 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is U51496MH2008PLC184997 and registration number is 184997. Currently company belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 465.56 Cr. and Equity Capital is Rs. 24.07 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
2008
Managing Director
Mr. Hemal V Mehta
NSE Symbol
--
Sudarshan Pharma Industries Management
| Name | Designation |
|---|---|
| Mr. Hemal V Mehta | Chairman & Managing Director |
| Mr. Sachin V Mehta | Joint Managing Director |
| Mrs. Jaya Ankur Singhania | Independent Director |
| Dr. Umesh Luthra | Independent Director |
| Dr. Anil Ghogare | Independent Director |
| Mr. Rushabh Patil | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹4,03,916.05 | ₹1,683.45  ₹1,676.85(0.39%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,49,205.29 | ₹5,620.45  ₹5,667.15(-0.82%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,18,065.23 | ₹1,461.90 ₹1,454.30(0.52%) | ₹1,317.600 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,03,430.62 | ₹3,056.05 ₹3,096.50(-1.31%) | ₹2,488.000 - ₹3,589.950 |
| Dr. Reddy's Laboratories | ₹92,453.48 | ₹1,107.95 ₹1,105.15(0.25%) | ₹1,093.000 - ₹1,420.200 |
FAQs on Sudarshan Pharma Industries
What is the share price of Sudarshan Pharma Industries?
The share price of Sudarshan Pharma Industries on 13 Mar, 2025 is ₹ 29.00.
What is 52W high and 52W low share price of Sudarshan Pharma Industries?
The highest and lowest 52W share prices of Sudarshan Pharma Industries are ₹ 53.500 and ₹ 5.820
What is the market cap of Sudarshan Pharma Industries?
The market capitalization of Sudarshan Pharma Industries as of 13 Mar, 2025 is ₹ 697.91 Crores
What is the P/E ratio of Sudarshan Pharma Industries?
The current P/E ratio of Sudarshan Pharma Industries as of 13 Mar, 2025 is 43.95
What is the PB ratio of Sudarshan Pharma Industries?
The PB ratio of Sudarshan Pharma Industries as of 13 Mar, 2025 is 0.62
Top Gainers
₹41.02
₹34.29 (0.20%)
₹8.84
₹7.37 (0.20%)
₹6.97
₹5.81 (0.20%)
₹194.70
₹162.25 (0.20%)
Top Losers
₹13.75
₹135.15 (-0.90%)
₹9.60
₹12.00 (-0.20%)
₹9.80
₹93.55 (-0.90%)
₹0.99
₹4.77 (-0.79%)
Market Indices
Sensex
₹73,828.91
₹74,029.76 (0.00%)